2022
DOI: 10.1016/j.atherosclerosis.2022.07.009
|View full text |Cite
|
Sign up to set email alerts
|

Long-term tracking and population characteristics of lipoprotein (a) in the Cardiovascular Risk in Young Finns Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 66 publications
0
2
0
Order By: Relevance
“…We studied 800 individuals aged 49 (44-53) years (68% women), including 17.8% with Lp(a) >50 mg/dl with a higher proportion of females in this subgroup (Table 1). The prevalence of Lp(a) >50 mg/dl was 18.4% in Germany, which is almost identical to our population while in Finland or Greece, it was 6.0% [5,6]. Our result is slightly lower than in the study by Ratajczak et al [3], which evaluated CVD risk factors in subjects aged 18-80 (median, 52 [43-60]) years, while we assessed younger subjects.…”
Section: Resultssupporting
confidence: 65%
“…We studied 800 individuals aged 49 (44-53) years (68% women), including 17.8% with Lp(a) >50 mg/dl with a higher proportion of females in this subgroup (Table 1). The prevalence of Lp(a) >50 mg/dl was 18.4% in Germany, which is almost identical to our population while in Finland or Greece, it was 6.0% [5,6]. Our result is slightly lower than in the study by Ratajczak et al [3], which evaluated CVD risk factors in subjects aged 18-80 (median, 52 [43-60]) years, while we assessed younger subjects.…”
Section: Resultssupporting
confidence: 65%
“…No association was found between serum phytosterol levels and Lp(a). This was expected, as the expression of Lp(a) is genetically determined and its levels are stable throughout the lifetime [ 23 ]. This lack of association would have been found had Lp(a) been measured in both follow-ups.…”
Section: Discussionmentioning
confidence: 99%
“…Participants were considered having hypertension if they had systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg or they were under antihypertensive medications 30 . Data on cardiovascular outcomes (N = 45) such as coronary artery disease, peripheral artery disease and atherosclerotic cerebrovascular disease, was obtained from national data registries and the Care Register for Health Care and the National Death Index 31 . Data on lipid-lowering (N = 62) and antihypertensive (N = 163) medication was self-reported while register-based data on diabetes medication (N = 22) was used.…”
Section: Methodsmentioning
confidence: 99%